FDA Rejects Oleandrin, Extract Pushed By MyPillow CEO, As A Dietary Supplement – Forbes

Share this Story

The agency concluded that Oleandrin cannot “reasonably be expected to be safe.”

Author: Rachel Sandler

READ MORE